Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective.
Importance of a specialty clinic for individuals with fragile X syndrome.
Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutation.
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).
Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective.
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective. Brain Sci. 2018 Dec 05; 8(12).
View in:
PubMed
authors with profiles
Elizabeth Berry-Kravis